MFDS — authorised 24 December 1953
- Marketing authorisation holder: ENDO PHARMS
- Status: likely_approved
🇰🇷 Xyosted (Autoinjector) in South Korea
MFDS authorised Xyosted (Autoinjector) on 24 December 1953
Marketing authorisation
Xyosted (Autoinjector) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Xyosted (Autoinjector) approved in South Korea?
Yes. MFDS authorised it on 24 December 1953.
Who is the marketing authorisation holder for Xyosted (Autoinjector) in South Korea?
ENDO PHARMS holds the South Korean marketing authorisation.